Editas Medicine, Inc. (EDIT)
2.785
+0.08
(+3.15%)
USD |
NASDAQ |
Sep 14, 12:44
Editas Medicine Price : 2.785 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 2.68 | 2.72 | 2.62 | 2.70 | 2.464M |
| Sep 10, 2026 | 2.77 | 2.77 | 2.62 | 2.65 | 2.549M |
| Sep 09, 2026 | 3.06 | 3.06 | 2.77 | 2.77 | 2.963M |
| Sep 08, 2026 | 3.20 | 3.215 | 3.01 | 3.03 | 2.276M |
| Sep 04, 2026 | 3.04 | 3.23 | 3.04 | 3.23 | 1.391M |
| Sep 03, 2026 | 3.09 | 3.13 | 3.00 | 3.08 | 1.378M |
| Sep 02, 2026 | 3.09 | 3.23 | 2.98 | 3.08 | 1.679M |
| Sep 01, 2026 | 3.00 | 3.155 | 2.98 | 3.07 | 1.227M |
| Aug 31, 2026 | 3.12 | 3.14 | 3.025 | 3.06 | 2.076M |
| Aug 28, 2026 | 3.25 | 3.41 | 3.15 | 3.16 | 3.272M |
| Aug 27, 2026 | 3.17 | 3.37 | 3.15 | 3.30 | 2.667M |
| Aug 26, 2026 | 3.40 | 3.515 | 3.16 | 3.18 | 2.948M |
| Aug 25, 2026 | 3.05 | 3.33 | 3.05 | 3.28 | 4.213M |
| Aug 24, 2026 | 3.14 | 3.18 | 2.97 | 3.00 | 2.062M |
| Aug 21, 2026 | 2.98 | 3.245 | 2.95 | 3.11 | 2.116M |
| Aug 20, 2026 | 3.17 | 3.229 | 2.92 | 2.94 | 4.262M |
| Aug 19, 2026 | 3.01 | 3.30 | 2.99 | 3.25 | 9.641M |
| Aug 18, 2026 | 2.89 | 2.99 | 2.80 | 2.88 | 2.233M |
| Aug 17, 2026 | 2.80 | 2.895 | 2.77 | 2.84 | 2.114M |
| Aug 14, 2026 | 2.81 | 2.845 | 2.715 | 2.82 | 1.478M |
| Aug 13, 2026 | 2.85 | 2.90 | 2.81 | 2.81 | 1.272M |
| Aug 12, 2026 | 2.96 | 3.025 | 2.82 | 2.84 | 1.630M |
| Aug 11, 2026 | 2.84 | 2.99 | 2.83 | 2.95 | 1.911M |
| Aug 10, 2026 | 2.84 | 2.900 | 2.79 | 2.81 | 1.465M |
| Aug 07, 2026 | 2.99 | 3.09 | 2.87 | 2.88 | 1.693M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Recursion Pharmaceuticals, Inc. | 3.38 |
| Geron Corp. | 1.38 |
| Halozyme Therapeutics, Inc. | 108.24 |
| Novavax, Inc. | 9.54 |
| AVITA Medical, Inc. | 10.33 |
Price Related Metrics
| PS Ratio | 5.992 |
| Price to Book Value | 4.061 |
| Earnings Yield | -26.74% |
| Market Cap | 427.58M |